|
ZNF791 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.06699110552699E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.07902617133504E-12 |
| Normal-vs-Stage2 |
1.30919997065604E-09 |
| Normal-vs-Stage3 |
5.80313574971569E-13 |
| Normal-vs-Stage4 |
1.6530110613644E-12 |
| Stage1-vs-Stage2 |
7.504000E-01 |
| Stage1-vs-Stage3 |
2.606000E-01 |
| Stage1-vs-Stage4 |
1.397570E-02 |
| Stage2-vs-Stage3 |
2.968800E-01 |
| Stage2-vs-Stage4 |
6.312300E-02 |
| Stage3-vs-Stage4 |
2.254600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.72413252750448E-13 |
| Normal-vs-AfricanAmerican |
2.05969999999001E-05 |
| Normal-vs-Asian |
3.17900150648143E-11 |
| Caucasian-vs-AfricanAmerican |
1.267190E-01 |
| Caucasian-vs-Asian |
9.841000E-01 |
| AfricanAmerican-vs-Asian |
2.099600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.4269037020922E-13 |
| Normal-vs-Female |
3.90409926609436E-12 |
| Male-vs-Female |
5.026000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.84219347846238E-12 |
| Normal-vs-Age(41-60Yrs) |
1.08724140801542E-12 |
| Normal-vs-Age(61-80Yrs) |
3.81195075505047E-12 |
| Normal-vs-Age(81-100Yrs) |
5.370700E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.377200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.117000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.858200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.934000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.756400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.692800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.498800E-03 |
| Classical-VS-Follicular |
3.305800E-01 |
| Classical-VS-Other |
1.481760E-01 |
| Classical-VS-Normal |
3.418698657498E-11 |
| Tall-VS-Follicular |
1.034770E-01 |
| Tall-VS-Other |
6.828800E-01 |
| Tall-VS-Normal |
1.85207404967969E-12 |
| Follicular-VS-Other |
3.040400E-01 |
| Follicular-VS-Normal |
1.36910482950725E-11 |
| Other-VS-Normal |
1.72139999998766E-06 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.68653979670808E-12 |
| Normal-vs-N1 |
2.12108108854636E-12 |
| N0-vs-N1 |
2.043600E-01 |
|
|
